Otsuka Pharmaceutical Factory Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Otsuka Pharmaceutical Factory Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014081
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:26
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Otsuka Pharmaceutical Factory Inc (Otsuka), a subsidiary of Otsuka Holdings Co Ltd is a provider of parenteral and enteral nutrition products. The company’s enteral nutrition products supplies nutrients such as glucose, proteins, fats, electrolytes, and vitamin. It offers over the counter products include antiseptics for treating minor skin conditions and injuries, products for treating dry skin and products for treating athlete’s foot and ringworm. The company also provides contract manufacturing services. It develops various technologies for technologies for plastic containers, films, and formulations. Otsuka is headquartered in Naruto, Tokushima, Japan.

Otsuka Pharmaceutical Factory Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Otsuka Pharmaceutical Factory Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Otsuka Pharmaceutical Factory Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Otsuka Pharmaceutical Factory Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Otsuka Pharmaceutical Factory Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Otsuka Pharmaceutical Factory Inc, Medical Devices Deals, 2011 to YTD 2017 9
Otsuka Pharmaceutical Factory Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Otsuka Pharmaceutical Factory Inc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Claris Lifesciences Forms Joint Venture With Otsuka Pharma Factory And Mitsui For Infusion Business 11
Otsuka Pharma Factory Enters Into Distribution Agreement With Fresenius Kabi Japan For HES Products 13
Otsuka Pharma Forms Joint Venture With Living Cell Technologies To Commercialize Diabecell 14
Licensing Agreements 16
Living Cell Technologies Enters into Licensing Agreement with Otsuka Pharma 16
OPF Enters into Licensing Agreement with Diatranz Otsuka 17
Equity Offering 18
Living Cell Technologies Completes Private Placement Of Shares For US$3.2 Million 18
Acquisition 19
Otsuka Pharma Acquires 20% Stake in Otsuka Pharma India from Claris for USD20 Million 19
Otsuka Techno and Nanjin Otsuka to Acquire 55% Stake in Changzhou Econ Drugs 20
Otsuka Techno and Otsuka Pharmaceutical Acquires 61.3% Stake in Nanjing Techbond Biomedical Material 21
Otsuka Pharmaceutical Factory Inc – Key Competitors 22
Otsuka Pharmaceutical Factory Inc – Key Employees 23
Otsuka Pharmaceutical Factory Inc – Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Joint Venture 24
Recent Developments 25
Strategy And Business Planning 25
Aug 23, 2017: Otsuka OPV, the Vietnamese Subsidiary of Otsuka Pharmaceutical Factory Announces the Construction of a New factory for the Distribution of High Quality IV Solution Products 25
Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26

List of Tables
Otsuka Pharmaceutical Factory Inc, Pharmaceuticals & Healthcare, Key Facts 2
Otsuka Pharmaceutical Factory Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Otsuka Pharmaceutical Factory Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Otsuka Pharmaceutical Factory Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Otsuka Pharmaceutical Factory Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Otsuka Pharmaceutical Factory Inc, Medical Devices Deals, 2011 to YTD 2017 9
Otsuka Pharmaceutical Factory Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Claris Lifesciences Forms Joint Venture With Otsuka Pharma Factory And Mitsui For Infusion Business 11
Otsuka Pharma Factory Enters Into Distribution Agreement With Fresenius Kabi Japan For HES Products 13
Otsuka Pharma Forms Joint Venture With Living Cell Technologies To Commercialize Diabecell 14
Living Cell Technologies Enters into Licensing Agreement with Otsuka Pharma 16
OPF Enters into Licensing Agreement with Diatranz Otsuka 17
Living Cell Technologies Completes Private Placement Of Shares For US$3.2 Million 18
Otsuka Pharma Acquires 20% Stake in Otsuka Pharma India from Claris for USD20 Million 19
Otsuka Techno and Nanjin Otsuka to Acquire 55% Stake in Changzhou Econ Drugs 20
Otsuka Techno and Otsuka Pharmaceutical Acquires 61.3% Stake in Nanjing Techbond Biomedical Material 21
Otsuka Pharmaceutical Factory Inc, Key Competitors 22
Otsuka Pharmaceutical Factory Inc, Key Employees 23
Otsuka Pharmaceutical Factory Inc, Subsidiaries 24
Otsuka Pharmaceutical Factory Inc, Joint Venture 24

★海外企業調査レポート[Otsuka Pharmaceutical Factory Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Meritage Midstream Services II LLC:石油・ガス:M&Aディール及び事業提携情報
    Summary Meritage Midstream Services II LLC (Meritage Midstream), a subsidiary of Howard Midstream Energy Partners LLC, is an oil and gas company that provides midstream services. The company offers natural gas gathering, compression and handling, NGL treating and processing; natural-gas liquids trea …
  • Tenaga Nasional Bhd (TENAGA):企業の財務・戦略的SWOT分析
    Tenaga Nasional Bhd (TENAGA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Universiteit Utrecht-製薬・医療分野:企業M&A・提携分析
    Summary Universiteit Utrecht (Universiteit Utrecht) is a research university that offers education programs. The university offers bachelors, master's, honor education, education for professionals, online education, training and other education courses. Its research areas include earth and sustainab …
  • A.G.Barr p.l.c.:企業の戦略・SWOT・財務情報
    A.G.Barr p.l.c. - Strategy, SWOT and Corporate Finance Report Summary A.G.Barr p.l.c. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • MDU Resources Group Inc Oil & Gas Exploration and Production Operations and Cost Analysis – 2017
    MDU Resources Group Inc Oil & Gas Exploration and Production Operations and Cost Analysis - 2017 Summary MDU Resources Group, Inc. (MDU) is an energy, and construction materials and services company. It mines aggregates and markets crushed stone, sand, gravel and related construction materials. The …
  • Bechtel Corporation:企業の戦略的SWOT分析
    Bechtel Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Prinova Group LLC:企業の戦略・SWOT・財務情報
    Prinova Group LLC - Strategy, SWOT and Corporate Finance Report Summary Prinova Group LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Cooper Energy Ltd (COE):企業の財務・戦略的SWOT分析
    Summary Cooper Energy Ltd (CEL) is an oil and gas exploration and production company that offers oil production programs. The company produces, and commercializes crude oil and natural gas products. It conducts exploration for oil and gas through a portfolio of prospective acreage in the Cooper, Otw …
  • TKH Group NV (TWEKA):企業の財務・戦略的SWOT分析
    TKH Group NV (TWEKA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Cardiovascular Systems Inc (CSII):医療機器:M&Aディール及び事業提携情報
    Summary Cardiovascular Systems Inc (CSI) is a medical device company that develops and commercializes products for the treatment of peripheral and coronary vascular disease. The company's products include peripheral orbital atherectomy system, coronary orbital atherectomy system, crowns, and accesso …
  • Endonovo Therapeutics Inc (ENDV):企業の製品パイプライン分析2018
    Summary Endonovo Therapeutics Inc (Endonovo Therapeutics) is a commercial stage development company that offers non-invasive medical devices and equipment. The company’s products include Electroceutical Therapy a FDA-Cleared for the palliative treatment of pain and post-surgical edema and CE Marked …
  • Nippon Paint Holdings Co Ltd (4612):企業の財務・戦略的SWOT分析
    Nippon Paint Holdings Co Ltd (4612) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Futuren (FTRN)-エネルギー分野:企業M&A・提携分析
    Summary Futuren, formerly Theolia SA, is a wind energy producer that prospects, develops, constructs, installs and operates wind power projects. It specializes in designing and building onshore wind plants. Futuren conducts these operations for its own account as well as for third parties. The compa …
  • Nagasaki University:製薬・医療:M&Aディール及び事業提携情報
    Summary Nagasaki University is an educational service provider that operates graduate schools, undergraduate schools, and research institutes. The university offers under graduate level education in the fields of economics, dentistry, pharmaceutical sciences, medicine, environmental studies, enginee …
  • Cellestia Biotech AG:製薬・医療:M&Aディール及び事業提携情報
    Summary Cellestia Biotech AG (Cellestia Biotech) is a biopharmaceutical company that develops anti-cancer drugs for the treatment of oncology and immunological disorders. The company's lead compound includes CB-103, a novel oral pan-NOTCH inhibitor for the treatment of NOTCH dependent leukemia, lymp …
  • The Second Cup Ltd.:企業の戦略・SWOT・財務分析
    The Second Cup Ltd. - Strategy, SWOT and Corporate Finance Report Summary The Second Cup Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Stellar Biotechnologies Inc (SBOT):企業の財務・戦略的SWOT分析
    Summary Stellar Biotechnologies Inc (Stellar Bio), formerly CAG Capital Inc is a provider of keyhole limpet hemocyanin proteins. The company offers potent immune-stimulating molecule used as an active pharmaceutical ingredient known as active immunotherapies or therapeutic vaccines and as an injecta …
  • The Netherlands Cancer Institute:製薬・医療:M&Aディール及び事業提携情報
    Summary The Netherlands Cancer Institute (NCI) is a research institute that offers cancer research and treatment services. The institute conducts research in the areas of cell biology, diagnostic oncology, medical oncology, molecular carcinogenesis, biochemistry, biological stress response, gene reg …
  • China Telecom Corporation Limited:戦略・SWOT・企業財務分析
    China Telecom Corporation Limited - Strategy, SWOT and Corporate Finance Report Summary China Telecom Corporation Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Merck & Co Inc (MRK):企業の財務・戦略的SWOT分析
    Merck & Co Inc (MRK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆